ADIM
ARVN icon

Alpha DNA Investment Management’s Arvinas ARVN Stock Holding History

Alpha DNA Investment Management’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,759
Closed -$526K – 189
2023
Q3 		$526K Buy
+26,759
New +$656K 0.22% 129
2021
Q2 		– Sell
-100
Closed -$6K – 138
2021
Q1 		$6K Hold
100
– – 0.01% 328
2020
Q4 		$8K Buy
+100
New +$3.45K 0.01% 315

Other funds holding ARVN

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alpha DNA Investment Management's ARVN Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of Arvinas (ARVN) in Q4 2023, closing a stake of 26,759 shares — an estimated $526K sold.

Alpha DNA Investment Management first reported a position in ARVN in Q4 2020 and held it in 3 quarters. The position peaked at $526K in Q3 2023. 212 funds tracked by Wall St. Rank hold ARVN as of Q4 2023.

  • Alpha DNA Investment Management reported no remaining Arvinas position as of Q4 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 26,759 Arvinas shares in Q4 2023, an estimated $526K.
  • Alpha DNA Investment Management first reported a position in Arvinas in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Arvinas position peaked at $526K in Q3 2023.
  • 212 funds tracked by Wall St. Rank held Arvinas as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.